#NewAseBioMember | “AseBio is much more than an association: it’s a living ecosystem that drives innovation in biotechnology and healthcare”

AseBio. What does your company's work bring to the table and what is its strength?

Carmen Jiménez Medina. At Medhionine, we saw a clear problem: scientific communication can be very complex, and medicine is becoming so specialized that no one can know it all. For example, it's unrealistic to be an expert in ophthalmology, fertility, and cardiology at the same time… and also master systematic reviews, clinical trial protocols, and write a blog.

Until now, traditional agencies and consultancies tried to fill this gap, but the sector needed a different approach. That's why we created our platform: we connect healthcare companies with freelance scientific experts.

But we're not just a marketplace. At Medhionine, we provide methodology, review, quality assurance, and tools, giving freelancers a structure that provides support without limiting their freedom, while companies enjoy agility, speed, transparency, and scientific rigor in every project.

In short, we deliver: agility + flexibility + scientific quality for the healthcare sector.

AseBio. What is AseBio for you?

Carmen Jiménez Medina. For us, AseBio is much more than an association: it's a living ecosystem that drives innovation in biotechnology and healthcare. It's a space where companies, professionals, and organizations connect to share scientific knowledge in a responsible, clear, and accessible way.

AseBio. When did you first hear about AseBio?

Carmen Jiménez Medina. We learned about AseBio at the very beginning of Medhionine, while exploring how to integrate into the Spanish biotech ecosystem. We were impressed by its role as a catalyst for the sector, and since then, we've followed its work and its efforts to drive innovation.

AseBio. What do you expect from being part of an association like AseBio?

Carmen Jiménez Medina. We want to learn, share, and collaborate with other organizations that also aim to make science clear and useful. We're interested in staying updated on trends and regulations, networking, creating professional and personal opportunities… and, of course, making friends.

At the same time, we hope to contribute our hallmark of clarity, rigor, and scientific quality to the entire AseBio community.

AseBio. What is the biggest challenge facing the biotech sector or your company?

Carmen Jiménez Medina. Our biggest challenge is changing the paradigm: moving away from the traditional agency model and becoming a technology-based platform that allows companies and freelancers to collaborate with speed, clarity, and trust, without ever compromising the scientific quality that defines our work.